Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cornelia Liedtke"'
Publikováno v:
Lancet (London, England). 389(10087)
Summary Triple-negative breast cancer is a heterogeneous disease and specific therapies have not been available for a long time. Therefore, conventional chemotherapy is still considered the clinical state of the art. Different subgroups of triple-neg
Autor:
Achim Rody, Cornelia Liedtke
Publikováno v:
Reviews on recent clinical trials. 12(2)
Patients with triple negative breast cancer (TNBC) are characterized by an unfavorable prognosis particularly when not responding well to anthracycline-taxane chemotherapy. This is due to a more aggressive biology in some cases but most importantly t
Publikováno v:
Reviews on recent clinical trials. 12(2)
Primary endocrine therapy is an option in cases of hormone receptor positive and HER2 negative non-metastatic breast cancer. Aromatase inhibitors are considered the therapy of choice in postmenopausal patients. In premenopausal patients aromatase inh
Autor:
Elmar Stickeler, Achim Rody, Erich-Franz Solomayer, Manuela Abel, Eberhard Müller, Gilda Schmidt, Christoph Gerlinger, Jan Endrikat, Rainer M. Bohle, Theresa Link, Pauline Wimberger, Stefan Stein, Ingolf Juhasz-Böss, Cornelia Liedtke, Tanja Fehm
Publikováno v:
Journal of cancer research and clinical oncology. 142(6)
Triple-negative breast cancer (TNBC) is characterized by a strong heterogeneity with regard to tumour biology as well as in the clinical course of the disease. This study aimed to analyse whether there are any prognostic factors enabling prediction o